87 documents found, page 1 of 9
Programa Nacional de Vigilância da Gripe: relatório da época 2019/2020
Pechirra, Pedro; Cristóvão, Paula; Costa, Inês; Conde, Patrícia; Silva, Susana; Torres, Ana Rita; Machado, Ausenda; Rodrigues, Ana PaulaRelatório anual do Programa Nacional de Vigilância da Gripe (PNVG). A presente publicação descreve a caraterização clínica e laboratorial da atividade gripal na época 2019/2020. O PNVG assegura a vigilância epidemiológica da gripe em Portugal, integrando as componentes de vigilância clínica e laboratorial. A componente clínica possibilita o cálculo de taxas de incidência permitindo descrever a intensidade e evo...
Tailored Perioperative Medicine For Frail Patients Undergoing Vascular Surgery:...
Miguel, Bernardo; Oliveira, Sarah; Valente Jorge, João; Conde, Patrícia; Alves, ÂngelaFrailty is a concept that is emerging as an important tool in the preoperative assessment of patients. The incidence of frailty in vascular surgery patients is high and is expected to increase concomitantly with the aging of the population. The identification of these patients and their optimization in the perioperative period can lead to an improvement in their outcomes with a reduction in morbidity and mortal...
Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 6...
Kissling, Esther; Hooiveld, Mariette; Sandonis Martín, Virginia; Martínez-Baz, Iván; William, Naoma; Vilcu, Ana-Maria; Mazagatos, Clara; Domegan, LisaThe I-MOVE-COVID-19 network collates epidemiological and clinical information on patients with coronavirus disease (COVID-19), including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virological characterisation in 11 European countries [1]. One component of I-MOVE-COVID-19 is the multicentre vaccine effectiveness (VE) study at primary care/outpatient level in nine European study sites in eight c...
Influenza vaccine effectiveness estimates using the test-negative design with d...
Gómez, Verónica; Kislaya, Irina; Machado, Ausenda; Pechirra, Pedro; Costa, Inês; Cristóvão, Paula; Conde, Patrícia; Guiomar, Raquel; Nunes, BaltazarBackground: The test-negative design (TND) has been used to monitor influenza vaccine effectiveness (IVE). Negative controls are those that tested negative for any influenza virus - however, there are issues related to the selection of the negative controls; As it is hypothesized a potential bias introduced by virus interference in TND, some authors suggest to use other respiratory virus as control group. Hence...
I-MOVE-COVID-19: uma rede europeia para investigar, prevenir e controlar a pand...
Gómez, Verónica; Machado, Ausenda; Rodrigues, Ana Paula; Kislaya, Irina; Conde, Patrícia; Costa, Inês; Cristóvão, Paula; Verdasca, Nuno; Guiomar, RaquelFace à pandemia da COVID-19, a vigilância epidemiológica tem um papel fundamental para a deteção precoce de casos e a monitorização da pandemia. A par com a vigilância epidemiológica, importa, também, investigar fatores protetores e de risco para COVID-19, bem como estimar a efetividade de intervenções para controlo da doença, desde a efetividade de intervenções terapêuticas, como a vacina ou de medidas de saúd...
Interim 2019/20 influenza vaccine effectiveness: six European studies, Septembe...
Rose, Angela; Kissling, Esther; Emborg, Hanne-Dorthe; Larrauri, Amparo; McMenamin, Jim; Pozo, Francisco; Trebbien, Ramona; Mazagatos, ClaraBackground: Influenza A(H1N1)pdm09, A(H3N2) and B viruses were co-circulating in Europe between September 2019 and January 2020. Aim: To provide interim 2019/20 influenza vaccine effectiveness (VE) estimates from six European studies, covering 10 countries and both primary care and hospital settings. Methods: All studies used the test-negative design, although there were some differences in other study characte...
Programa Nacional de Vigilância da Gripe: relatório da época 2018/2019
Pechirra, Pedro; Cristóvão, Paula; Costa, Inês; Conde, Patrícia; Guiomar, Raquel; Rodrigues, Ana Paula; Silva, Susana; Torres, Ana RitaRelatório anual do Programa Nacional de Vigilância da Gripe (PNVG). A presente publicação descreve a caraterização clínica e laboratorial da atividade gripal na época 2018/2019. O PNVG assegura a vigilância epidemiológica da gripe em Portugal, integrando as componentes de vigilância clínica e laboratorial. A componente clínica possibilita o cálculo de taxas de incidência permitindo descrever a intensidade e evo...
Influenza Vaccine Effectiveness in Portugal: Season 2018-19 report
Gómez, Verónica; Kislaya, Irina; Pechirra, Pedro; Conde, Patrícia; Costa, Inês; Nunes, Baltazar; Guiomar, Raquel; Machado, AusendaThe results to be presented are related to the 2018/19 EuroEVA season (the Portuguese component of the multicentre I-MOVE study) and aimed to estimate the end of season influenza vaccine effectiveness i) in general population; ii) in <65 and ≥65 years age groups; iii) in the target group for vaccination and iv) by influenza A subtype.
Epidemiology and genetic variability of respiratory syncytial virus in Portugal...
Sáez-López, Emma; Cristóvão, Paula; Costa, Inês; Pechirra, Pedro; Conde, Patrícia; Guiomar, Raquel; Peres, Maria João; Viseu, Regina; Lopes, PauloRespiratory syncytial virus (RSV) is associated with substantial morbidity and mortality since it is a predominant viral agent causing respiratory tract infections in infants, young children and the elderly. Considering the availability of the RSV vaccines in the coming years, molecular understanding in RSV is necessary.
Hospital-based test negative case control study to measure seasonal influenza v...
Gómez, Verónica; Kislaya, Irina; Pechirra, Pedro; Conde, Patrícia; Costa, Inês; Cristóvão, Paula; Nunes, Baltazar; Guiomar, Raquel; Machado, AusendaObjectives: The aim of the EVA Hospital study was to measure IVE against influenza laboratory confirmed SARI hospitalized in the older adult population at national level and contribute to the European estimate. In specific, it was intended to estimate 2018-19 seasonal influenza VE against SARI laboratoryconfirmed influenza requiring hospitalization, when possible: by age group (65-79 years, 80+ years) and; by p...